HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A Retzow Selected Research

Levodopa (L Dopa)

7/2001Influence of the dopamine agonist alpha-dihydroergocryptine on the pharmacokinetics of levodopa in patients with Parkinson's disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


A Retzow Research Topics

Disease

2Parkinson Disease (Parkinson's Disease)
07/2001 - 11/2000
1Mania (Manias)
04/2000
1Asthenia
04/2000
1Body Weight (Weight, Body)
04/2000

Drug/Important Bio-Agent (IBA)

2Dopamine Agonists (Dopamine Agonist)IBA
07/2001 - 11/2000
2Dihydroergocryptine (Dihydroergocryptine Mesylate)FDA Link
07/2001 - 11/2000
1Levodopa (L Dopa)FDA LinkGeneric
07/2001
1Antipsychotic Agents (Antipsychotics)IBA
04/2000
1Valproic Acid (Depakote)FDA LinkGeneric
04/2000
1PerazineIBA
04/2000
1Haloperidol (Haldol)FDA LinkGeneric
04/2000

Therapy/Procedure

1Therapeutics
04/2000